Related Experiment Video

Updated: Aug 1, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

The chronic leukemias. Clinical picture, diagnosis, and management

D D Hurd

    Postgraduate Medicine
    |May 1, 1983
    PubMed

    Insights

    Chronic leukemias, including CML and CLL, present insidiously. While chemotherapy and other treatments exist, allogeneic bone marrow transplantation offers potential cures for chronic myelogenous leukemia.

    Area of Science:

    • Hematology
    • Oncology

    Background:

    • Chronic leukemias, including chronic myelogenous leukemia (CML) and chronic lymphocytic leukemia (CLL), affect approximately 12,000 individuals annually in the US.
    • Hairy cell leukemia (HCL) and prolymphocytic leukemia (PLL) are less common forms.
    • These conditions often present with vague symptoms such as fatigue, malaise, night sweats, and weight loss.

    Purpose of the Study:

    • To provide an overview of the incidence, presentation, and treatment of various chronic leukemias.
    • To highlight recent advancements in treatment modalities, particularly for CML.

    Main Methods:

    • Review of epidemiological data for chronic leukemias in the United States.
    • Summary of current treatment strategies, including chemotherapy, splenectomy, splenic irradiation, and leukapheresis.
    • Discussion of emerging therapies such as allogeneic bone marrow transplantation.

    Main Results:

    • Chemotherapy is the primary treatment for CML and CLL.
    • Splenectomy is the preferred treatment for HCL.
    • Allogeneic bone marrow transplantation is a promising curative approach for CML when administered early.

    Conclusions:

    • Chronic leukemias are serious conditions with varied treatment approaches.
    • Allogeneic bone marrow transplantation represents a significant advancement, offering potential cures for CML.
    • Further research and early intervention are crucial for improving patient outcomes in chronic leukemias.

    More Related Videos

    Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

    Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

    Published on: November 26, 2018

    Assessment of the Metabolic Profile of Primary Leukemia Cells06:21

    Assessment of the Metabolic Profile of Primary Leukemia Cells

    Published on: November 21, 2018

    Related Concept Videos

    COPD: Pathogenesis and Clinical Features01:20

    COPD: Pathogenesis and Clinical Features

    Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
    The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
    Disorders of Leukocytes01:27

    Disorders of Leukocytes

    Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
    Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
    Chronic Obstructive Pulmonary Disease-V: Management01:29

    Chronic Obstructive Pulmonary Disease-V: Management

    Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
    Smoking Cessation
    Chronic Kidney Disease II: Clinical Manifestations01:24

    Chronic Kidney Disease II: Clinical Manifestations

    Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
    Chronic Kidney Disease III: Interprofessional Care01:28

    Chronic Kidney Disease III: Interprofessional Care

    Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
    Chronic Kidney Disease IV: Nursing Management01:18

    Chronic Kidney Disease IV: Nursing Management

    Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...